Platelet Aggregation, Arachidonic Acid (Optical)

This test evaluates how your platelets clump together when exposed to arachidonic acid using optical aggregometry. A blood sample is processed to create platelet‑rich plasma, then the lab measures changes in light passing through the sample as platelets respond to the agonist.

It primarily assesses the cyclooxygenase‑1 pathway that is targeted by aspirin. Clinicians often order it as part of a broader platelet function panel that uses different agonists to understand how well your platelets work.

Results help your care team determine whether a tendency to bruise or bleed might be related to a platelet function problem, the effect of aspirin or similar drugs, or another medical condition. The test is commonly used to confirm drug effect, to investigate suspected inherited or acquired platelet disorders, and to plan safely for procedures where bleeding control is important.

It can also support monitoring of adherence to aspirin therapy or identify unexpected resistance or sensitivity. Understanding your platelet response helps tailor medication choices and guides whether further testing is needed.

A reduced response may reflect the expected effect of aspirin, other drug interference, or a problem within the same biochemical pathway. A typical response suggests no significant inhibition at the time of testing, while a stronger than expected response may be seen in some individuals or clinical states. Your clinician interprets the result alongside other agonists, your medical history, and the complete blood count.

If results are unclear, your team may repeat the test after holding certain medications when medically safe, or add complementary studies such as other platelet agonists, von Willebrand testing, or genetic evaluations. Always review any medication changes with your clinician before stopping or starting treatments.